Related Experiment Video

Updated: May 11, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease

Elisa Araldi1, Aranzazu Chamorro-Jorganes, Coe van Solingen

  • 1New York University School of Medicine, 522 First Avenue, Smilow 703, New York, NY 10016. carlos.fernandez-hernando@nyumc.org.

Current Vascular Pharmacology
|May 30, 2013
PubMed

Insights

Atherosclerosis is a chronic inflammatory arterial disease. MicroRNAs regulate vascular cell functions, offering potential therapeutic applications for atherosclerosis and related vascular diseases.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Gene Regulation

Background:

  • Atherosclerosis is a chronic inflammatory arterial disease characterized by lipid-laden lesions.
  • Endothelial cell activation recruits monocytes, leading to chronic inflammation and lesion progression.
  • Advanced lesions can rupture, causing myocardial infarction and stroke.

Purpose of the Study:

  • To review the role of microRNAs in regulating vascular cell functions.
  • To explore the involvement of microRNAs in atherosclerosis pathogenesis.
  • To discuss the therapeutic potential of microRNAs in vascular diseases.

Main Methods:

  • Literature review of microRNA functions in vascular biology.
  • Analysis of microRNA-mediated regulation in atherosclerosis.
  • Synthesis of current knowledge on microRNA therapeutics for vascular conditions.

Main Results:

  • MicroRNAs are key post-transcriptional regulators of vascular cell differentiation, migration, proliferation, and inflammation.
  • MicroRNAs influence angiogenesis, neointimal formation, and lipid metabolism.
  • Dysregulation of specific microRNAs is implicated in atherosclerosis development and progression.

Conclusions:

  • MicroRNAs play a critical role in regulating cellular processes underlying atherosclerosis.
  • MicroRNAs represent promising therapeutic targets for managing atherosclerosis and other vascular diseases.
  • Further research into microRNA-based therapies holds significant potential for cardiovascular medicine.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...